Company / Free Cash Flow per Share
MADRIGAL PHARMACEUTICALS, INC. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$8.64
FY2025
5-year range
-$22.99 / -$8.64
FY2021-FY2025
Trend
+62.4%
vs FY2024
Sector context
#185 of 192
Health Care
What the data says
Among 192 Health Care companies, MADRIGAL PHARMACEUTICALS, INC. is in the bottom 4% for free cash flow per share. Free Cash Flow per Share returned to growth in FY2025 after 6 years of decline, reaching $-8.64.
Based on SEC 10-K filings.
-8.64 in FY2025.
Improved from $-17.99 to $-8.64 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 192This company -$8.64 Sector average -$19.84
▼
+56.5% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 62.4% year-over-year.
- Ranks #185 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2018.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$8.64 | +62.4% |
| FY2024 | -$22.99 | -27.8% |
| FY2023 | -$17.99 | -37.0% |
| FY2022 | -$13.13 | -10.6% |
| FY2021 | -$11.87 | -16.0% |
| FY2020 | -$10.23 | -276.9% |
| FY2019 | -$2.71 | -57.4% |
| FY2018 | -$1.73 | +5.9% |
| FY2017 | -$1.83 | +45.8% |
| FY2016 | -$3.38 | -264.7% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026